Weatherford International plc — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Weatherford International plc filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $4.33B | Feb 8, 2023 |
| FY2022 | Dec 31, 2021 | $3.65B | Feb 8, 2023 |
| FY2022 | Dec 31, 2020 | $3.69B | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $261.00M | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | $4.95B | Feb 17, 2022 |
| FY2019 | Sep 30, 2019 | $1.31B | Mar 16, 2020 |
| FY2019 | Jun 30, 2019 | $1.31B | Mar 16, 2020 |
| FY2019 | Mar 31, 2019 | $1.35B | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | $1.43B | Mar 16, 2020 |
| FY2019 | Sep 30, 2018 | $1.44B | Mar 16, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $1.49B | Feb 14, 2018 |
| FY2017 | Sep 30, 2017 | $1.46B | Feb 14, 2018 |
| FY2017 | Jun 30, 2017 | $1.36B | Feb 14, 2018 |
| FY2017 | Mar 31, 2017 | $1.39B | Feb 14, 2018 |
| FY2017 | Dec 31, 2016 | $1.41B | Feb 14, 2018 |
| FY2017 | Sep 30, 2016 | $1.36B | Feb 14, 2018 |
| FY2017 | Jun 30, 2016 | $1.40B | Feb 14, 2018 |
| FY2017 | Mar 31, 2016 | $1.59B | Feb 14, 2018 |
| FY2016 | Dec 31, 2015 | $2.01B | Feb 15, 2017 |
| FY2016 | Sep 30, 2015 | $2.24B | Feb 15, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Dec 31, 2019 | $53.00M | Mar 16, 2020 |
| FY2019 | Sep 30, 2019 | $307.00M | Mar 16, 2020 |
| FY2019 | Jun 30, 2019 | $290.00M | Mar 16, 2020 |
| FY2019 | Mar 31, 2019 | $264.00M | Mar 16, 2020 |
| FY2019 | Dec 31, 2018 | $308.00M | Mar 16, 2020 |
| FY2019 | Sep 30, 2018 | $339.00M | Mar 16, 2020 |
| FY2019 | Jun 30, 2018 | $305.00M | Mar 16, 2020 |
| FY2019 | Mar 31, 2018 | $278.00M | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $192.00M | Feb 15, 2019 |
| FY2018 | Sep 30, 2017 | $264.00M | Feb 15, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $431.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $506.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $417.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $26.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | ($450.00M) | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | ($1.92B) | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | ($26.00M) | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | $3.66B | Feb 17, 2022 |
| FY2019 | Sep 30, 2019 | ($821.00M) | Mar 16, 2020 |
| FY2019 | Jun 30, 2019 | ($316.00M) | Mar 16, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $756.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $938.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $820.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $412.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $116.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | ($1.49B) | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $1.00M | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | ($1.18B) | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | ($2.08B) | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | ($2.17B) | Mar 16, 2020 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $108.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $123.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $112.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $90.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $85.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $97.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $7.00M | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | $136.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $139.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $158.00M | Mar 16, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $676.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $792.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $832.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $349.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $322.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $210.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $61.00M | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | ($747.00M) | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | ($242.00M) | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | ($388.00M) | Mar 16, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $226.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $299.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $209.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $132.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | $85.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | $154.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2019 | $20.00M | Feb 17, 2022 |
| FY2021 | Dec 13, 2019 | $250.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $186.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $225.00M | Mar 16, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.20B | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $5.16B | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | $5.07B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $4.72B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.77B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $5.43B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $7.29B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $6.60B | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $9.75B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $12.66B | Feb 14, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.50B | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $3.88B | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | $4.15B | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $4.17B | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $4.28B | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $4.50B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $4.38B | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $10.27B | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | $10.32B | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | $10.60B | Feb 14, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.70B | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $1.29B | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | $924.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $535.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $472.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $907.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $2.88B | Feb 19, 2021 |
| FY2021 | Dec 12, 2019 | $2.93B | Feb 17, 2022 |
| FY2019 | Dec 31, 2018 | ($3.71B) | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | ($626.00M) | Feb 15, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2020 | Dec 31, 2020 | $0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2019 | $239.00M | Feb 19, 2021 |
| FY2020 | Dec 13, 2019 | $0 | Feb 19, 2021 |
| FY2020 | Dec 31, 2018 | $713.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2017 | $2.73B | Mar 16, 2020 |
| FY2018 | Dec 31, 2016 | $2.80B | Feb 15, 2019 |
| FY2017 | Dec 31, 2015 | $2.80B | Feb 14, 2018 |
| FY2016 | Dec 31, 2014 | $3.01B | Feb 15, 2017 |
| FY2015 | Dec 31, 2013 | $3.29B | Feb 16, 2016 |
| FY2014 | Dec 31, 2012 | $3.87B | Feb 18, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.13B) | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | ($1.49B) | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | ($1.95B) | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | ($2.37B) | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | ($2.40B) | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | ($1.95B) | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | ($26.00M) | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | ($8.67B) | Mar 16, 2020 |
| FY2018 | Jan 1, 2018 | ($5.76B) | Feb 15, 2019 |
| FY2018 | Dec 31, 2017 | ($5.76B) | Feb 15, 2019 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $987.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $916.00M | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | $958.00M | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | $910.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | $951.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | $1.12B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $618.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | $602.00M | Mar 16, 2020 |
| FY2019 | Dec 31, 2017 | $613.00M | Mar 16, 2020 |
| FY2019 | Dec 31, 2016 | $1.04B | Mar 16, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42B | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $1.59B | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | $1.83B | Feb 6, 2025 |
| FY2021 | Dec 31, 2021 | $2.37B | Feb 17, 2022 |
| FY2021 | Dec 31, 2020 | $2.55B | Feb 17, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | (6) | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | (27) | Feb 8, 2023 |
| FY2016 | Dec 31, 2016 | 0 | Feb 15, 2017 |
| FY2016 | Sep 30, 2016 | (1) | Feb 15, 2017 |
| FY2016 | Jun 30, 2016 | 0 | Feb 15, 2017 |
| FY2016 | Mar 31, 2016 | 0 | Feb 15, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5 | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | 6 | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 6, 2025 |
| FY2023 | Dec 31, 2021 | (6) | Feb 7, 2024 |
| FY2022 | Dec 31, 2020 | (27) | Feb 8, 2023 |
| FY2016 | Dec 31, 2016 | 0 | Feb 15, 2017 |
| FY2016 | Sep 30, 2016 | (1) | Feb 15, 2017 |
| FY2016 | Jun 30, 2016 | 0 | Feb 15, 2017 |
| FY2016 | Mar 31, 2016 | 0 | Feb 15, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 71.60M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | 72.10M | Feb 4, 2026 |
| FY2024 | Dec 31, 2023 | 72.10M | Feb 6, 2025 |
| FY2023 | Dec 31, 2022 | 71.00M | Feb 7, 2024 |
| FY2022 | Dec 31, 2021 | 70.00M | Feb 8, 2023 |
| FY2021 | Dec 31, 2020 | 70.00M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | 70.00M | Feb 19, 2021 |
| FY2019 | Dec 31, 2018 | 1.00B | Mar 16, 2020 |
| FY2018 | Dec 31, 2017 | 993.00M | Feb 15, 2019 |
| FY2017 | Dec 31, 2016 | 983.00M | Feb 14, 2018 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2024 | $36.00M | Feb 4, 2026 |
| FY2025 | Dec 31, 2023 | $0 | Feb 4, 2026 |
| FY2024 | Dec 31, 2022 | $0 | Feb 6, 2025 |